SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-23-174589
Filing Date
2023-06-26
Accepted
2023-06-26 09:20:35
Documents
4
Group Members
CLEOPATRA ACQUISITION CORP.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d460085dsctota.htm SC TO-T/A 22261
2 EX-99.(A)(5)(IV) d460085dex99a5iv.htm EX-99.(A)(5)(IV) 14044
3 EX-99.(A)(5)(V) d460085dex99a5v.htm EX-99.(A)(5)(V) 10846
4 GRAPHIC g460085dsp6.jpg GRAPHIC 3456
  Complete submission text file 0001193125-23-174589.txt   53793
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-48459 | Film No.: 231039613
SIC: 2834 Pharmaceutical Preparations

Mailing Address TOMTEBODAVAGEN 23A STOCKHOLM V7 SE-112 76
Business Address TOMTEBODAVAGEN 23A STOCKHOLM V7 SE-112 76 46 8 697 20 00
Swedish Orphan Biovitrum AB (publ) (Filed by) CIK: 0001789731 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC TO-T/A